Correction to: Nature Communications https://doi.org/10.1038/s41467-020-16256-y, published online 4 May 2020.
The competing interests section of the original article contained an error. In the sentence “A patent application has been filed on 12 March 2020 on monoclonal antibodies targeting SARS-CoV-2 (United Kingdom patent application no. 2003632.3”, the number 2003632 was hyperlinked in error to an irrelevant page. The link has been removed both from the PDF and the HTML version of the article.
About this article
Cite this article
Wang, C., Li, W., Drabek, D. et al. Publisher Correction: A human monoclonal antibody blocking SARS-CoV-2 infection. Nat Commun 11, 2511 (2020). https://doi.org/10.1038/s41467-020-16452-w
Virology Journal (2021)
An alphavirus replicon-based vaccine expressing a stabilized Spike antigen induces protective immunity and prevents transmission of SARS-CoV-2 between cats
npj Vaccines (2021)
Biomedical Microdevices (2020)
Nature Communications (2020)